European Launch of Proxima

  • Proxima supports rapid and frequent bedside blood gas measurements
  • European launch on target and builds on UK launch

Cambridge, UK, 18 March 2015: Sphere Medical Holding plc (AIM: SPHR.L), (“Sphere Medical” or the “Company”), a leading provider of innovative monitoring and diagnostic devices for the critical care setting, today announces the European launch of Proxima, its cutting edge in-line patient dedicated arterial blood gas analyser, at the 35th International Symposium on Intensive Care and Emergency Medicine (ISICEM), Brussels, 17-20 March.

Sales will be initially targeted within the Netherlands, Belgium and German markets through a small, direct sales team.  Learnings from the recent UK launch supported by the considerable experience of the Medical Advisory Board are proving instrumental in facilitating entry into these important new markets.

Sphere Medical’s Chief Executive Officer, Wolfgang Rencken, said: “Europe represents a significant opportunity for sales of Proxima. The support of our hugely experienced Medical Advisory Board and their endorsement of Proxima, will assist with the sales effort and we look forward to providing further updates on developments.”

Commenting on the clinical importance of Proxima, Professor Michael Quintel, Director of the Department of Anaesthesiology, Emergency and Intensive Care Medicine at the University of Göttingen, Germany, said: “Proxima addresses some important issues in the management of unstable critically ill patients. The launch of this product offers some exiting new opportunities for intensive care medicine in Germany.”

The Proxima system will be displayed at Stand 1.35 at ISICEM 2015.